BEIJING (Reuters) - China's Kintor Pharmaceutical said on Wednesday its potential COVID-19 treatment proxalutamide effectively reduced the risk of hos.
BEIJING (Reuters) - China's Kintor Pharmaceutical said on Wednesday its potential COVID-19 treatment proxalutamide effectively reduced the risk of hos.